# Regenerative Medical Technology Group Inc.

Regenerative Medical Technology Group Inc. is a public company listed on OTC as RMTG, headquartered in Boca Raton, FL, United States.

## Company overview

- **Legal name:** Regenerative Medical Technology Group Inc.
- **Former names in filing history:** MESO NUMISMATICS, INC. (2018-12-12 to 2024-10-24)
- **Classification:** Public company
- **Industry (SIC):** 5990 — Retail-Retail Stores, NEC
- **Headquarters:** Boca Raton, FL, United States
- **Fiscal year end:** December 31
- **Ticker:** OTC: RMTG
- **SEC CIK:** 0001760026

## About

Regenerative Medical Technology Group Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001760026, and its reported industry is Retail-Retail Stores, NEC. In 10-K filed on 2026-05-14, it reported annual revenue of USD 5,100,315; net income of USD -7,812,409; total assets of USD 4,488,694 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2025 (period ended 2025-12-31)

- **Revenue:** $5.1M (USD 5,100,315)
- **Net income:** -$7.8M (USD -7,812,409)
- **Total assets:** $4.5M (USD 4,488,694)
- **Cash and equivalents:** $956,718 (USD 956,718)
- **Operating cash flow:** -$706,519 (USD -706,519)

### FY2024 (period ended 2024-12-31)

- **Revenue:** $4.1M (USD 4,107,494)
- **Net income:** -$5.6M (USD -5,562,971)
- **Total assets:** $3.8M (USD 3,821,429)
- **Operating cash flow:** $850,699 (USD 850,699)

### FY2023 (period ended 2023-12-31)

- **Revenue:** $2.4M (USD 2,409,953)
- **Net income:** -$9.8M (USD -9,813,666)
- **Total assets:** $2.9M (USD 2,879,103)
- **Cash and equivalents:** $530,540 (USD 530,540)
- **Operating cash flow:** -$419,200 (USD -419,200)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $1.5M (USD 1,530,223)
- **Net income:** -$5.5M (USD -5,506,822)
- **Total assets:** $8.1M (USD 8,080,273)
- **Operating cash flow:** -$1.1M (USD -1,114,136)

## Recent SEC filings

- Form 8-K — filed 2026-08-25 — period 2026-08-20 — CURRENT REPORT
- Form 10-Q — filed 2026-08-19 — period 2026-06-30 — QUARTERLY REPORT
- Form 10-Q — filed 2026-06-09 — period 2026-03-31 — QUARTERLY REPORT
- Form 10-K — filed 2026-05-14 — period 2025-12-31 — ANNUAL REPORT
- Form 10-Q — filed 2025-11-19 — period 2025-09-30 — QUARTERLY REPORT
- Form 10-Q — filed 2025-08-19 — period 2025-06-30 — QUARTERLY REPORT
- Form 8-K — filed 2025-05-21 — period 2025-05-21 — CURRENT REPORT
- Form 10-Q — filed 2025-05-20 — period 2025-03-31 — QUARTERLY REPORT
- Form 10-K — filed 2025-04-15 — period 2024-12-31 — ANNUAL REPORT
- Form 8-K — filed 2024-11-19 — period 2024-11-19 — CURRENT REPORT
- Form 10-Q — filed 2024-11-19 — period 2024-09-30 — QUARTERLY REPORT
- Form 8-K — filed 2024-10-24 — period 2024-10-21 — CURRENT REPORT

---

Updated: 2026-10-23T06:52:41Z

Canonical page: https://altss.com/profile/regenerative-medical-technology-group-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology